Ozempic could help reduce Alzheimer’s risk for some, study suggests: ‘Shifting the paradigm’

Semaglutide medications — such as Ozempic, the popular diabetes drug — have been linked to a reduced risk of Alzheimer’s disease for certain groups. A new study, which was led by researchers at Case Western Reserve University in Cleveland, Ohio, revealed that patients who were prescribed semaglutide had a “significantly lower risk” of developing Alzheimer’s […]